Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federica Sarno

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Frontiers in Oncology|June 13, 2020
The Pan-Sirtuin Inhibitor MC2494 Regulates Mitochondrial Function in a Leukemia Cell LineVincenzo Carafa, Rosita Russo, Laura Della Torre, et al.
Biomedicines|January 21, 2023
Functional Validation of the Putative Oncogenic Activity of <i>PLAU</i>Federica Sarno, Désirée Goubert, Emilie Logie, et al.
Frontiers in Nutrition|August 23, 2021
A Root in Synapsis and the Other One in the Gut Microbiome-Brain Axis: Are the Two Poles of Ketogenic Diet Enough to Challenge Glioblastoma?Liliana Montella, Federica Sarno, Lucia Altucci, et al.
Clinical Epigenetics|December 22, 2023
In-silico guided chemical exploration of KDM4A fragments hitsJessica Lombino, Rosario Vallone, Maura Cimino, et al.
European Journal of Medicinal Chemistry|November 17, 2020
Novel quinolone-based potent and selective HDAC6 inhibitors: Synthesis, molecular modeling studies and biological investigationNicola Relitti, A Prasanth Saraswati, Giulia Chemi, et al.
Clinical Epigenetics|March 31, 2021
Clinical epigenetics settings for cancer and cardiovascular diseases: real-life applications of network medicine at the bedsideFederica Sarno, Giuditta Benincasa, Markus List, et al.
Cancers|February 21, 2020
Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and DegradationClemens Zwergel, Rossella Fioravanti, Giulia Stazi, et al.
Cancers|March 28, 2024
Correction: Zwergel et al. Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation. <i>Cancers</i> 2020, <i>12</i>, 447Clemens Zwergel, Rossella Fioravanti, Giulia Stazi, et al.
European Journal of Medicinal Chemistry|August 10, 2018
Novel spiroindoline HDAC inhibitors: Synthesis, molecular modelling and biological studiesMargherita Brindisi, Johanna Senger, Caterina Cavella, et al.
Clinical Epigenetics|May 8, 2019
Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cellsClemens Zwergel, Michael Schnekenburger, Federica Sarno, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|June 13, 2020
The Pan-Sirtuin Inhibitor MC2494 Regulates Mitochondrial Function in a Leukemia Cell LineVincenzo Carafa, Rosita Russo, Laura Della Torre, et al.
Biomedicines|January 21, 2023
Functional Validation of the Putative Oncogenic Activity of <i>PLAU</i>Federica Sarno, Désirée Goubert, Emilie Logie, et al.
Frontiers in Nutrition|August 23, 2021
A Root in Synapsis and the Other One in the Gut Microbiome-Brain Axis: Are the Two Poles of Ketogenic Diet Enough to Challenge Glioblastoma?Liliana Montella, Federica Sarno, Lucia Altucci, et al.
Clinical Epigenetics|December 22, 2023
In-silico guided chemical exploration of KDM4A fragments hitsJessica Lombino, Rosario Vallone, Maura Cimino, et al.
European Journal of Medicinal Chemistry|November 17, 2020
Novel quinolone-based potent and selective HDAC6 inhibitors: Synthesis, molecular modeling studies and biological investigationNicola Relitti, A Prasanth Saraswati, Giulia Chemi, et al.
Clinical Epigenetics|March 31, 2021
Clinical epigenetics settings for cancer and cardiovascular diseases: real-life applications of network medicine at the bedsideFederica Sarno, Giuditta Benincasa, Markus List, et al.
Cancers|February 21, 2020
Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and DegradationClemens Zwergel, Rossella Fioravanti, Giulia Stazi, et al.
Cancers|March 28, 2024
Correction: Zwergel et al. Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation. <i>Cancers</i> 2020, <i>12</i>, 447Clemens Zwergel, Rossella Fioravanti, Giulia Stazi, et al.
European Journal of Medicinal Chemistry|August 10, 2018
Novel spiroindoline HDAC inhibitors: Synthesis, molecular modelling and biological studiesMargherita Brindisi, Johanna Senger, Caterina Cavella, et al.
Clinical Epigenetics|May 8, 2019
Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cellsClemens Zwergel, Michael Schnekenburger, Federica Sarno, et al.
Pageof 4